Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Ali, Muatsim A.M
Accelerates symptom recovery, reduces illness severity, enhances immune response, decreases inflammation, and supports natural healing
Like semaglutide and tirzepatide, it is a glucagon-like peptide-1 (GLP-1) agonist, meaning it acts on GLP-1 receptors just like the natural GLP-1 hormone in your body
Injectable GHK-Cu vs Topical Formulations GHK-Cu is available in both topical creams and serums and injectable formulations
At therapeutic IV doses (often 2550 g in oncology and critical-care research), studies report improvements in inflammation markers, oxidative stress, and quality of life in advanced cancer and sepsis, although evidence is strongest for adjunctive rather than standalone use
The key difference is that retatrutide provides triple agonism (GLP-1 + GIP + glucagon) while semaglutide provides only GLP-1 agonism
